Ken Griffin Orasure Technologies Inc Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$4.2 - $6.18 $5,040 - $7,416	-1,200 Reduced 12.37%	8,500 $36,000
Q1 2024 May 15, 2024	BUY	$6.08 - $8.28 $27,968 - $38,088	4,600 Added 90.2%	9,700 $59,000
Q4 2023 Feb 14, 2024	SELL	$5.13 - $8.35 $7,695 - $12,525	-1,500 Reduced 22.73%	5,100 $41,000
Q3 2023 Nov 14, 2023	BUY	$4.4 - $6.91 $14,080 - $22,112	3,200 Added 94.12%	6,600 $39,000
Q2 2023 Aug 14, 2023	SELL	$4.88 - $7.39 $30,256 - $45,818	-6,200 Reduced 64.58%	3,400 $17,000
Q1 2023 May 15, 2023	SELL	$4.66 - $6.52 $49,862 - $69,764	-10,700 Reduced 52.71%	9,600 $58,000
Q4 2022 Feb 14, 2023	SELL	$3.7 - $5.29 $8,510 - $12,167	-2,300 Reduced 10.18%	20,300 $97,000
Q3 2022 Nov 14, 2022	SELL	$2.72 - $4.61 $51,952 - $88,051	-19,100 Reduced 45.8%	22,600 $86,000

220

67.2M

8.5K

11.8K

Ticker OSUR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 72,619,104
Market Cap $308M
Description
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.